Related Experiment Video
Updated: Jun 8, 2026

07:45
A Manual Small Molecule Screen Approaching High-throughput Using Zebrafish Embryos
Published on: November 8, 2014
Zebrafish: A tool for chemical screens.
1Department of Developmental Biology, University of Pittsburgh, Pennsylvania 15213, USA. tsang@pitt.edu
Birth Defects Research. Part C, Embryo Today : Reviews
|September 23, 2010
Summary
Zebrafish are powerful vertebrate models for developmental biology and drug discovery. New tools like fluorescent reporter lines and automated screening enable high-throughput chemical analysis in live embryos.
Area of Science:
- Developmental Biology
- Pharmacology
- Genetics
Background:
- Zebrafish (Danio rerio) are established vertebrate models in developmental biology research.
- Technological advancements are expanding zebrafish utility into drug discovery.
- Existing methods allow for visualization of biological processes in live zebrafish embryos.
Purpose of the Study:
- To review recent technological advancements enhancing zebrafish use in drug discovery.
- To highlight innovations enabling high-throughput chemical screening using zebrafish.
- To showcase zebrafish as a valuable tool for identifying novel therapeutic compounds.
Main Methods:
- Generation of transgenic zebrafish reporter lines for in vivo fluorescence imaging.
- Application of automated imaging and high-content analysis for chemical screens.
- Utilizing small molecule treatments to assess drug effects in zebrafish embryos.
Main Results:
- Transgenic reporter lines facilitate direct visualization of drug effects in live embryos.
- Automated screening platforms enable rapid analysis of large compound libraries.
- Zebrafish models are increasingly effective for high-throughput chemical screens.
Conclusions:
- Technological innovations have significantly advanced zebrafish's role in drug discovery.
- Zebrafish offer a powerful platform for identifying and developing new pharmaceuticals.
- The combination of genetic tools and automated screening accelerates the drug discovery pipeline.

